Cumberland Pharmaceuticals share price logo

Cumberland Pharmaceuticals

NASDAQ: CPIX

$8.55

+0.07

(+0.83%)

Live

as on

Cumberland Pharmaceuticals Stock Performance

as on October 24, 2026 at 6:27 am IST

  • Day's Low

    Day's High

    $8.33
    $8.75
    downward going graph

    2.57%

    Downside

    2.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.85
    $9.28
    downward going graph

    78.36%

    Downside

    8.54%

    Upside

    downward going graph

Cumberland Pharmaceuticals share price movements today

Previous Close
$8.48
Open
$8.33
Volume
144.5K
Market Cap
$119.3M
Dividend Yield
16.97%
Day's Low - High
$8.33 - $8.75
52 Week Low - High
$1.85 - $9.28

Cumberland Pharmaceuticals Historical Returns

1 Month Return
+ 6.8 %
3 Month Return
+ 21.4 %
1 Year Return
+ 141.6 %
3 Year Return
+ 321.89 %
5 Year Return
+ 216.42 %

Cumberland Pharmaceuticals Stock Fundamentals & Key Indicators

Check Cumberland Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$119.3M

EPS (TTM)

-0.7144

Dividend Yield

16.97%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-11.44

Industry PE ratio

-9.79

PEG Ratio

0.08

EBITDA

-5.1M

Revenue (TTM)

31.3M

Profit Margin

83.37%

Return On Equity TTM

-47.10%

Cumberland Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cumberland Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Cumberland Pharmaceuticals image
Cumberland Pharmaceuticals
Hold$119.3M216.42%-11.4483.37%16.97%
Sandoz Group Ltd Sponsored ADR image
Sandoz Group Ltd Sponsored ADR
Buy$41.2BNA63.9047.54%1.08%
United Therapeutics image
United Therapeutics
StrongBuy$24.2B206.16%18.6486.14%0.00%
Viatris image
Viatris
Buy$21.4B32.57%-51.2534.83%2.60%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
Buy$44.3BNA20.5465.57%1.98%
See all

Stock Returns calculator for Cumberland Pharmaceuticals Stock including INR - Dollar returns

The Cumberland Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cumberland Pharmaceuticals investment value today

Current value as on today

₹2,63,462

Returns

₹1,63,462

(+163.46%)

Returns from Cumberland Pharmaceuticals Stock

₹1,43,590 (+143.59%)

Dollar Impact

₹19,872 (+19.87%)

Analyst Recommendation on Cumberland Pharmaceuticals Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Cumberland Pharmaceuticals. Average target price of $8.5

Cumberland Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Cumberland Pharmaceuticals.

What analysts predicted

-0.59%DOWNSIDE

Target Price

$8.5

Current Price

$8.55

Analyzed by

6 Analysts

Target

$8.50

Cumberland Pharmaceuticals target price $8.5, a slight downside of -0.59% compared to current price of $8.55. According to 6 analysts rating.

Indian Investors' Interest in Cumberland Pharmaceuticals Stock

Search interest for Cumberland Pharmaceuticals Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:29% versus previous 30 day period

Cumberland Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
8
9
9
10
11
10
8
13
9
0
Gross Profit
6
8
7
8
10
8
7
11
7
0
Operating Income
-1
-1
-1
-1
1
0
-1
-1
-3
-3
EBITDA
0
0
0
0
2
0
0
0
-1
-3
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
0
Income Before Tax
-1
-1
-1
-1
1
0
-1
-1
-3
-3
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-1
-1
-1
-1
1
0
-1
-1
-3
-4
Net Profit Margin
81.46%
82.63%
85.44%
81.06%
87.83%
81.44%
88.08%
83.61%
78.82%
77.53%

Cumberland Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
41
40
34
37
35
42
39
37
44
Gross Profit
33
33
26
28
27
32
33
31
37
Operating Income
-4
-7
-9
-6
-7
-5
-9
-6
-2
EBITDA
-1
-8
-4
-1
0
0
0
0
2
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
2
2
4
4
4
5
5
6
5
Income Before Tax
-3
-7
-9
-6
-5
-5
-6
-6
-2
Income Tax Expense
4
0
0
0
0
0
0
0
0
Net Income
-7
-6
-3
-3
-3
-5
-6
-6
-2
Net Profit Margin
82.09%
81.89%
78.42%
76.89%
75.51%
78.29%
84.66%
82.61%
85.02%

Cumberland Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-1
-1
-1
1
0
-1
-1
-3
-4
Operating Cash Flow
-2
0
0
1
3
0
0
0
0
0
Investing Cash Flow
0
0
0
0
-1
0
0
-3
0
-1
Financing Cash Flow
2
0
0
-1
-5
0
0
0
0
-5
Change in Cash
0
-1
0
0
-2
0
0
-3
0
-7

Cumberland Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-7
-3
-3
-3
-5
-6
-6
-2
Operating Cash Flow
0
3
3
5
6
8
6
0
4
Investing Cash Flow
9
-27
2
-1
0
-13
0
0
-4
Financing Cash Flow
1
7
-5
-7
-3
-2
-7
0
-6
Change in Cash
10
-17
0
-3
2
-7
-1
0
-6

Global Institutional Holdings in Cumberland Pharmaceuticals

Check out the Institutions with significant holdings in Cumberland Pharmaceuticals.

Funds
Holdings
Vanguard
2.50%
VANGUARD INDEX FUNDS
2.41%
Bridgeway Funds, Inc.
1.08%
DFA INVESTMENT DIMENSIONS GROUP INC
0.84%
Joseph Edelman
0.65%
See all

Insights on Cumberland Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CPIX stock has moved up by 18.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CPIX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CPIX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 13.67M → 166.45K (in $), with an average decrease of 65.7% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.41M → -4.11M (in $), with an average decrease of 76.7% per quarter

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets. The company's existing product line includes: Acetadote: an injectable solution for treating acetaminophen poisoning. Caldolor: an injectable medication for managing pain and fever. Kristalose: a prescription oral laxative solution effective for chronic and acute constipation. Omeclamox-Pak: used in the treatment of Helicobacter pylori infection and duodenal ulcer disease. Vaprisol: an injectable therapy for euvolemic and hypervolemic hyponatremia. Vibativ: an injectable antibiotic prescribed for severe bacterial infections, including those acquired in hospitals or associated with ventilators, as well as complex skin and skin structure infections. In its development pipeline, Cumberland is advancing: RediTrex injection: designed to treat active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, along with disabling psoriasis. Ifetroban: a product candidate currently in Phase II clinical trials for aspirin-exacerbated respiratory disease, systemic sclerosis, and Duchenne muscular dystrophy. It has also completed Phase II clinical trials for hepatorenal syndrome and portal hypertension, with further clinical investigation ongoing for its potential use in progressive fibrosing interstitial lung diseases. An additional product candidate in Phase II clinical trials, aimed at reducing cholesterol levels for hospital use. Founded in 1999, the company's corporate headquarters are located in Nashville, Tennessee.
OrganisationCumberland Pharmaceuticals
Headquarters2525 West End Avenue, Nashville, TN, 37203, US
IndustryDrug Manufacturers - Specialty & Generic
CEOA. J. Kazimi

Key Management of Cumberland Pharmaceuticals

Name

Title

Mr. A. J. Kazimi MBA

Founder, Chairman, President & CEO

Mr. John Michael Hamm C.M.A.

Vice President Accounting & Finance and CFO

Mr. Todd M. Anthony

Vice President of Organizational Development

Mr. Adam S. Mostafa

Managing Director of Banking & Investor Relations

FAQs

What is Cumberland Pharmaceuticals share price today?

Cumberland Pharmaceuticals share price today is $8.55 as on . Cumberland Pharmaceuticals share today touched a day high of $8.75 and a low of $8.33.

What is the 52 week high and 52 week low for Cumberland Pharmaceuticals share?

Cumberland Pharmaceuticals share touched a 52 week high of $9.28 on and a 52 week low of $1.85 on . Cumberland Pharmaceuticals stock price today i.e. is trending at $8.55,which is 7.87% down from its 52 week high and 362.16% up from its 52 week low.

What is Cumberland Pharmaceuticals's market capitalisation today?

Cumberland Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Cumberland Pharmaceuticals Stock (CPIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cumberland Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cumberland Pharmaceuticals Stock (CPIX) from India?

Indian investors can start investing in Cumberland Pharmaceuticals (CPIX) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Cumberland Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Cumberland Pharmaceuticals share’s latest price of $8.55 as on October 24, 2026 at 12:57 am IST, you will get 1.1696 shares of Cumberland Pharmaceuticals. Learn more about fractional shares .

What are the returns that Cumberland Pharmaceuticals has given to Indian investors in the last 5 years?

Cumberland Pharmaceuticals stock has given 216.42% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?